Home > Clinical Trials by Conditions > "A" Clinical Trial Conditions > Asthma Clinical Trials
Asthma Clinical Trials
A 24 Week Study of Daily Oral Investigational Drug vs Placebo in Patients with Asthma
Condition: pfizer_clinical_trials.html
Pfizer
Activation and Function of Eosinophils in Conditions with Blood or Tissue Eosinophilia
Condition: national_institute_of_allergy_and_infectious_diseases_niaid_clinical_trials.html
National Institute of Allergy and Infectious Diseases (NIAID)
Assessment of Lung Inflammation in Patients with Atopic Asthma Using Positron Emission Tomography
Condition: national_institute_of_allergy_and_infectious_diseases_niaid_clinical_trials.html
National Institute of Allergy and Infectious Diseases (NIAID)
Asthma Clinical Research Network (ACRN)
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Asthma Partnership for Minority Children
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Asthma Severity in Children and Environmental Agents
Condition: national_institute_of_environmental_health_sciences_niehs_clinical_trials.html
National Institute of Environmental Health Sciences (NIEHS)
Borage Oil and Ginkgo Biloba (EGb 761) in Asthma
Condition: national_center_for_complementary_and_alternative_medicine_nccam_clinical_trials.html
National Center for Complementary and Alternative Medicine (NCCAM)
Characterizing a 5P-Linked BHR Susceptibility Locus
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Childhood Asthma Management Program (CAMP) Phases I and II
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Childhood Asthma Program in NYC Health Department Clinics
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Chronic Life Stress and Incident Asthma in Adult Women
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Clinical Epidemiology of Asthma in An HMO
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Clinical Trial of Acid Reflux Therapy in Asthma
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Community Based Study of Adult Onset Asthma
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Community Based Study on Occupational Asthma
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Community Organizing Network for Environmental Health
Condition: national_institute_of_environmental_health_sciences_niehs_clinical_trials.html
National Institute of Environmental Health Sciences (NIEHS)
Comparative effectiveness of a breath-operated albuterol inhaler in asthma patients with poor inhaler technique
Condition: ivax_research_clinical_trials.html
IVAX Research
Controlling Asthma at School
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Development and Evaluation of Community Asthma Program
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Early Risk Predictors For Chronic Pulmonary Disease
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Efficacy and Safety of Fexofenadine in Mild to Moderate Persistent Asthma
Condition: aventis_pharmaceuticals_clinical_trials.html
Aventis Pharmaceuticals
Efficacy and Safety of Fexofenadine in Mild to Moderate Persistent Asthma
Condition: aventis_pharmaceuticals_clinical_trials.html
Aventis Pharmaceuticals
Efficacy and Safety of Nasonex vs. Placebo in Subjects with SAR and Concomitant Asthma
Condition: integrated_therapeutics_group_clinical_trials.html
Integrated Therapeutics Group
Endotoxin and Bronchial Inflammation in Asthma
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Epidemiology of Airway Responsiveness
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Epidemiology of Idiopathic Dilated Cardiomyopathy (Washington, DC Dilated Cardiomyopathy Study)
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Evaluation of various doses of Ro 27-2771 (test drug) in asthmatic patients not treated with inhaled corticosteroids
Condition: hoffmannla_roche_clinical_trials.html
Hoffmann-La Roche
Factors Involved in Asthma and Airway Inflammation
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
FLASH Study: A study of roflumilast versus placebo in patients with asthma
Condition: altana_pharma_clinical_trials.html
ALTANA Pharma
Genetic Epidemiology of Asthma in Costa Rica
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Genetics of Airway Responsiveness and Lung Function
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Genetics of Asthma and Bronchial Hyperresponsiveness
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Geographic Modeling of Traffic and Asthma Rates
Condition: national_institute_of_environmental_health_sciences_niehs_clinical_trials.html
National Institute of Environmental Health Sciences (NIEHS)
Home Based Environmental Adherence Trial
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Honolulu Heart Program
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Inhaled Corticosteroid Replacement Study - Efficacy and Safety of Ro 27-2441 (test drug) in Moderate Persistent Asthma
Condition: hoffmannla_roche_clinical_trials.html
Hoffmann-La Roche
Intervention for Hispanic Children with Asthma
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Intervention to Improve Asthma Management/Prevention
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Interventions to Improve Asthma Management/Prevention at School
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Isocyanate Antigens and T Cells That Cause Asthma
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Leukotriene Polymorphisms and Montelukast Response - Ancillary to LoDo Trial
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Long Term Safety Study of Levalbuterol and Racemic Albuterol in Subjects Twelve Years of Age and Older with Asthma
Condition: sepracor_inc_clinical_trials.html
Sepracor, Inc.
Long-term Safety Performance of Fexofenadine in Asthma
Condition: aventis_pharmaceuticals_clinical_trials.html
Aventis Pharmaceuticals
Longitudinal Study of Asthma From Birth to Adulthood
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Magnesium and Asthma - Clinical Trials
Condition: national_center_for_complementary_and_alternative_medicine_nccam_clinical_trials.html
National Center for Complementary and Alternative Medicine (NCCAM)
Mechanisms of Allergen Immunotherapy
Condition: national_institute_of_allergy_and_infectious_diseases_niaid_clinical_trials.html
National Institute of Allergy and Infectious Diseases (NIAID)
Modification of Allergic Immunologic Response by Leukotriene Antagonists - Ancillary to ACRN IMPACT
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Multicenter Asthma Research Collaboration
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
NHLBI/NICHD Collaborative Studies of Asthma in Pregnancy
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Occupation and Asthma in an Urban Low Income Population
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Asthma Clinical Trials
|
